Kwality Pharmaceuticals Ltd
KPLKwality Pharmaceuticals Ltd
KPLPrice Chart
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is overpriced and in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
34.14 | 4.43 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.29 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Kwality Pharmaceuticals Limited manufactures and exports pharmaceutical formulations for human and veterinary use.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 74.53 | 99.53 | 138.29 | 166.90 | 142.96 | 263.60 | 459.70 | 253.97 | 309.00 | 341.89 | ||||||||||
Raw Materials | 57.48 | 72.19 | 104.00 | 114.19 | 92.59 | 165.50 | 203.11 | 113.27 | 154.66 | 272.97 | ||||||||||
Power & Fuel Cost | 2.31 | 2.81 | 2.76 | 3.71 | 4.20 | 6.13 | 11.07 | 12.98 | 17.23 | |||||||||||
Employee Cost | 2.16 | 3.60 | 4.89 | 7.74 | 10.92 | 14.70 | 18.80 | 28.16 | 30.46 | |||||||||||
Selling & Administrative Expenses | 5.35 | 8.91 | 11.07 | 13.71 | 19.59 | 41.70 | 48.74 | 32.64 | 30.91 | |||||||||||
Operating & Other expenses | 1.85 | 1.91 | 3.10 | 11.22 | -2.22 | 5.12 | 2.80 | 19.79 | 14.70 | |||||||||||
EBITDA | 5.38 | 10.11 | 12.47 | 16.33 | 17.88 | 30.45 | 175.18 | 47.13 | 61.04 | 68.92 | ||||||||||
Depreciation/Amortization | 1.69 | 2.51 | 2.98 | 3.12 | 4.43 | 6.49 | 10.69 | 14.96 | 19.56 | 18.54 | ||||||||||
PBIT | 3.69 | 7.60 | 9.49 | 13.21 | 13.45 | 23.96 | 164.49 | 32.17 | 41.48 | 50.38 | ||||||||||
Interest & Other Items | 1.22 | 1.95 | 2.21 | 2.29 | 2.52 | 2.68 | 2.92 | 6.61 | 10.39 | 10.98 | ||||||||||
PBT | 2.47 | 5.65 | 7.28 | 10.92 | 10.93 | 21.28 | 161.57 | 25.56 | 31.09 | 39.40 | ||||||||||
Taxes & Other Items | 0.92 | 2.28 | 2.75 | 3.35 | 2.60 | 6.12 | 41.57 | 6.21 | 7.30 | 10.53 | ||||||||||
Net Income | 1.55 | 3.37 | 4.53 | 7.57 | 8.33 | 15.16 | 120.00 | 19.35 | 23.79 | 28.87 | ||||||||||
EPS | 0.77 | 2.22 | 4.37 | 7.30 | 8.03 | 14.61 | 115.65 | 18.65 | 22.93 | 27.82 | ||||||||||
DPS | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Kwality Pharmaceuticals Ltd | 41.42 | 4.43 | — |
Sun Pharmaceutical Industries Ltd | 45.32 | 6.47 | 0.75% |
Cipla Ltd | 31.05 | 4.77 | 0.82% |
Mankind Pharma Ltd | 57.20 | 11.43 | — |
Price Comparison
Compare KPL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
KPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJan 5, 2017
Dividend/Share
₹0.60
Ex DateEx Date
Jan 5, 2017
Net profit of Kwality Pharmaceuticals rose 35.74% to Rs 8.47 crore in the quarter ended September 2024 as against Rs 6.24 crore during the previous quarter ended September 2023. Sales rose 29.26% to Rs 90.03 crore in the quarter ended September 2024 as against Rs 69.65 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales90.0369.65 29 OPM %21.8421.87 - PBDT17.1813.05 32 PBT12.558.17 54 NP8.476.24 36 Powered by Capital Market - Live
Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live
Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
Net profit of Kwality Pharmaceuticals rose 54.24% to Rs 8.36 crore in the quarter ended June 2024 as against Rs 5.42 crore during the previous quarter ended June 2023. Sales rose 18.72% to Rs 80.08 crore in the quarter ended June 2024 as against Rs 67.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales80.0867.45 19 OPM %21.6520.42 - PBDT15.1411.98 26 PBT11.127.20 54 NP8.365.42 54 Powered by Capital Market - Live
Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 13.11%, vs industry avg of 9.03%
Constant Market Share
Over the last 5 years, market share stayed at 0.08%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 25.74%, vs industry avg of 15.28%